![]() Revive Therapeutics Revive Therapeutics is a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases. | Emerald Health Pharmaceuticals Emerald Health Pharmaceuticals (EHP) is a biotech company that provides medicines based on cannabinoid science. | ![]() Medipure Pharmaceuticals Medipure Pharmaceuticals is a company that focuses on discovering and developing proprietary endocannabinoid system-based prescription drugs. | InMed Pharmaceuticals InMed Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of cannabinoid-based therapeutics for the treatment of diseases with unmet medical needs. | Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies is a biopharmaceutical company focused on cannabinoid drug development. | |
Founding Date | Founding Date 2012 | Founding Date 2017 | Founding Date 2014 | Founding Date 2014 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Toronto, CA HQ | Locations San Diego, US HQ | Locations North Vancouver, CA HQ Burnaby, CA | Locations Vancouver, CA HQ Vancouver, CA | Locations Oxford, GB HQ London, GB |
Employees | Employees N/A | Employees 1713% increase | Employees 525% increase | Employees 13 | Employees 713% decrease |
Valuation ($) | Valuation ($) 2.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $4.9m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $1.7m (FY, 2025) | Gross profit N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 11.6m | Total funding raised $ 9.9m |
Emerald Health Pharmaceuticals (EHP) is a biotech company that provides medicines based on cannabinoid science.
View company
Medipure Pharmaceuticals is a company that focuses on discovering and developing proprietary endocannabinoid system-based prescription drugs.
View companyInMed Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of cannabinoid-based therapeutics for the treatment of diseases with unmet medical needs.
View companyOxford Cannabinoid Technologies is a biopharmaceutical company focused on cannabinoid drug development.
View company